Comprehensive Cancer Center Vienna: Difference between revisions
| Line 4: | Line 4: | ||
</div> | </div> | ||
== [[hasExperts:: | == [[hasExperts::Experts_(Comprehensive_Cancer_Center_Vienna)|Experts]] == | ||
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | ||
The [[dct:title::Comprehensive Cancer Center Vienna]] team is only active in a coordinating role. Patients are cared for without exception in the corresponding oncological special outpatient clinics [https://www.ccc.ac.at/patientinnen/terminvereinbarung/]. | The [[dct:title::Comprehensive Cancer Center Vienna]] team is only active in a coordinating role. Patients are cared for without exception in the corresponding oncological special outpatient clinics [https://www.ccc.ac.at/patientinnen/terminvereinbarung/]. | ||
Revision as of 13:55, 1 November 2023
Go back to Cancer Centers list.
Trials
Experts
The Comprehensive Cancer Center Vienna team is only active in a coordinating role. Patients are cared for without exception in the corresponding oncological special outpatient clinics [1].
CCC Research Cluster
Diagnostic and Therapeutic Developments
Experimental Therapy and Drug Resistance
Microenvironment, Vasculature and Metastasis
CCC Units
Breast Health Center (CCC-BGZ)
Central Nervous System Tumor Unit (CCC-CNS)
Colorectal Cancer Unit (CCC-CRC)
Gastroesophageal Tumor Unit (CCC-GET)
Gynecologic Cancer Unit (CCC-GCU)
Musculoskeletal Tumors Unit (CCC-MST)
Neuroendocrine Tumor Unit (CCC-NET)
Pancreatic Cancer Unit (CCC-PCU)
Urologic Oncology Unit (CCC-UO)
CCC Platforms
Drug & Target Screening Platform (CCC-DTS)
Personalized Medicine at the CCC: Platform for Molecular Diagnostics and Treatment in Oncology
Platform for Cancer Nursing Research
Platform for Side Effects Management, Supportive Care & Rehabilitation (CCC-SMSCR)
Learning Resources
Course: Cancer Update CCC Vienna
Content type: State-of-the-art advanced training series for doctors about Lymphomas; Bladder and kidney cancer; Head and Neck Cancer; Gastric and esophageal carcinoma.
Target audience: Doctors.
Access: Information and registration [2].
Course: PhD Programme
Content type: PhD programmes on Clinical and Experimental Oncology; Inflammation and Immunity; Malignant Diseases; Clinical Neurosciences (CLINS).
Target audience: Doctors.
Access: Information [3].
Course: Postgraduate Oncology Training
Content type: Postgraduate training on Medscape Oncology; Fellowship Gynecological Oncology.
Target audience: Doctors.
Access: Information [4].
Course: Vienna International Summer School on Oncology for Medical Students
Content type: To help students to become familiar with cancer care in general health practice to reduce fear for patients with a malignant disease and to develop and nourish international and intercultural relationships.
Target audience: Medical students.
Novel Therapies and Diagnostic Methods
Diagnostics
| Radiology | |||
|---|---|---|---|
| Type | Name | Availibility | Uses per year |
| Machine | CT scanners | yes | |
| Machine | MRI (specify the strength and field of the techniques) | yes | |
| Machine | Mammography (please specify analogic mammography or digital) | yes (digital) | |
| Machine | Ultrasound | yes | |
| Technique | MRI-guided biopsy | yes | |
| Technique | Stereostatic biopsy | yes | |
| Technique | Ultrasound guided biopsy | yes | |
| Technique | E/S Fine-needle biopsy | yes | |
| Technique | Angiography | yes | |
| Nuclear Medicine | |||
| Type | Name | Availibility | Uses per year |
| Machine | PET CT | yes | |
| Machine | PET/MRI | yes | |
| Facility | Radionuclide treatment facilities | yes | |
| Machine | SPECT | yes | |
| Machine | SPECT CT | yes | |
| Technique | Sentinel node scintigraphy | yes | |
| Technique | Bone scintigraphy | yes | |
| Pathology | |||
| Type | Name | Availibility | Uses per year |
| Machine | Electron microscopy | yes | |
| Facility | Cytology laboratory | yes | |
| Facility | Histopathology laboratory | yes | |
| Technique | FISH (Fluorescence In Situ Hybridization) | yes | |
| Technique | PCR (Polymerase Chain Reaction) | yes | |
| Technique | Liquid biopsy | yes | |
| Technique | Cytogenetics | yes | |
| Pathology: Molecular Tests | |||
| Type | Name | Availibility | Uses per year |
| Technique | PI3KCA | yes | |
| Technique | HER2 status | yes | |
| Others | |||
| Type | Name | Availibility | Uses per year |
| Technique | Bronchoscopy | yes | |
| Technique | Colposcopy | yes |
Treatment
| Surgical Oncology | |||
|---|---|---|---|
| Type | Name | Availibility | Uses per year |
| Specialist | Breast surgery | yes | |
| Specialist | Thoracic surgery | yes | |
| Specialist | Digestive surgery | yes | |
| Specialist | Neurosurgery | yes | |
| Specialist | Gynaecological surgery | yes | 180 |
| Specialist | Head and neck surgery | yes | |
| Specialist | Oncoplastic surgery | yes | |
| Specialist | Paediatric surgery | yes | |
| Specialist | ENT surgery | yes | |
| Technique | Robotic surgery | yes | |
| Technique | spinal decompression surgery for vertebral metastases | yes | |
| Radiotherapy | |||
| Type | Name | Availibility | Uses per year |
| Machine | Brachytherapy unit | yes | |
| Technique | Radiosurgery | yes | |
| Machine | Gamma Knife | 1 | 1400 |
| Hemato-Oncology / Bone Marrow Transplants | |||
| Type | Name | Availibility | Uses per year |
| Facility | Transfusion Unit | yes | |
| Facility | Cellular therapy unit with GMP (Good Manufacturing Practice) | yes | |
| Technique | Allogenic stem cell transplants | yes | 87 (2022) |
| Technique | Autologous bone marrow transplants | yes | |
| Technique | Autologous stem cell transplants | yes | 43 (2022) |
| Specialists | |||
| Type | Name | Availibility | Uses per year |
| Specialist | Radiotherapist | yes | |
| Specialist | Psychologist or Psychotherapist | yes | |
| Specialist | Social worker | yes | |
| Specialist | Spiritual care | yes | |
| Specialist | Physiotherapist | yes | |
| Specialist | Dietitian | yes | |
| Others | |||
| Type | Name | Availibility | Uses per year |
| Facility | 24-hour Oncological Emergency Department | yes | |
| Facility | Clinical Trial Center | yes | |
| Facility | Phase 1 Clinical Trial Unit | yes |
Prevention
| Screening and Others | |||
|---|---|---|---|
| Type | Name | Availibility | Uses per year |
| Facility | Breast cancer screening program | yes | |
| Facility | Cervical cancer screening program | yes |
Palliative Care
| Others | |||
|---|---|---|---|
| Type | Name | Availibility | Uses per year |
| Facility | Hospice unit (in the hospital structure or affiliated) | yes | |
| Facility | Home palliative care availability | yes |
Course: Cancer School CCC Vienna
Content type: Basic course on cancer knowledge; advanced course on cancer knowledge.
Target audience: Affected people; relatives; people who are professionally involved with cancer diseases and patients; patient representatives.
EHDEN Participation
The Medical University of Vienna is part of the EHDEN Network of Data Partners.
The European Health Data and Evidence Network (EHDEN) aims to standardize European health data using OMOP-CDM to facilitate research. The project creates a federated network of data sources for easy access by researchers and policymakers. Its goal is to improve healthcare outcomes through better data quality and interoperability.
Primary purpose: The primary purpose of the Philips IntelliSpace Critical Care and Anesthesia (ICCA) system in the Department of Anaesthesia, Intensive Care Medicine and Pain Medicine is to manage and store intra- and perioperative patient data in various care settings like ICUs, operating theatres, and PACUs.
Type of information: The database includes vital signs, medication, interventions, clinical notes, and other related information across multiple care environments.
Data level: Regional level.
Number of records: 350,000 patients.
Data range: 2021 onwards.
Open Data Access: Data is not publicly available. Instructions for data request [10].
Contact information: Contact [11].
